India Biochip Market Size and Forecast (2026–2034), Regional Growth, Trend, Share and Industry Analysis Report Coverage: By Type (DNA Chips, Protein Chips, Lab-on-a-Chip (LOC), Cell Arrays, Others); By Product (Consumables, Instruments, Software and Services); By Application (Disease Diagnostics, Drug Discovery and Development, Genomics, Agricultural Biotechnology, Others); By End User (Biotechnology and Pharmaceutical Companies, Hospitals and Diagnostic Centers, Academic and Research Institutes, Others)


PUBLISHED ON
2026-11-17
CATEGORY NAME
Healthcare
AUTHOR NAME
Swetal (Research Analyst)

Description

India Biochip Market Overview 

The India biochip market is projected to expand from USD 0.25 billion in 2026 to USD 0.72 billion by 2034, registering a CAGR of 14.7% during 2026–2034. India's biochip market is becoming a crucial segment of both biotechnology and advanced diagnostics, with sustained growth expected from rising demand for rapid disease diagnosis, molecular diagnostics, personalized medicine, and high-throughput drug discovery. The increase in the number of infectious and chronic disease burdens, expanding pharmaceutical and biotechnology R&D, and the need for faster, more accurate diagnostic solutions have increased demand for DNA chips, protein chips, cell-based chips, and lab-on-chip technologies. While microarray-based technologies are widely used in genotyping and gene expression analysis, microfluidics is advancing point-of-care diagnostics, integrated diagnostic cartridge development, and laboratory miniaturization. Government efforts that promote the manufacturing of medical devices and biotechnology innovation have facilitated the growth of local companies, such as Molbio Diagnostics, Achira Labs, Huwel Lifesciences, and PathShodh Healthcare, that create locally-produced diagnostic and biosensing technology. However, the high cost of development and validation and a lack of advanced manufacturing capabilities within the country for chips, as well as the reliance on imported technologies and affordability constraints of small diagnostic facilities continue to limit commercialization.

India Biochip Market Size

India Biochip Market Growth Drivers

Increasing Demand for Rapid and Decentralized Molecular Diagnostics

Increasing demand for timely identification of diseases and for quick diagnostic turnaround along with effective multi-purpose testing outside the centralized laboratory system is driving the demand for biochip-based diagnostic solutions in India. Micro-PCR chips, lab-on-chip devices and different types of integrated molecular diagnostics cartridges are widely used for sample preparation and analysis with minimal manual work input. The introduction of these devices in diagnostics of infectious diseases including tuberculosis and cancer helps to expand the market for such devices since they can be used in cheap public health facilities, small laboratories, and point-of-care settings. For example, Truenat by Molbio Diagnostics utilizes the technology of micro-PCR chips and portable systems to detect tuberculosis and other infections. Its use in decentralized testing shows how chip-based technology enables the use of molecular diagnostics in the field where the conventional laboratory infrastructure is inaccessible.

Expansion of Pharmaceutical and Biotechnology Research Activities

The rise in investment in pharma R&D, genomics, drug discovery, and precision medicine is driving the need for DNA chips, protein chips, cell-based chips, and microfluidic research technologies. The pharmaceutical and biotech sectors are requiring advanced analytical instruments to study biological interactions, discover disease biomarkers, and expedite the drug development process. Biochips provide decreased sample use and increased test efficacy, opening doors for dedicated local manufacturers and technology providers. For instance, Achira Labs’ Fabchip microfluidic technology shows how small chips can be used in multi-testing applications. The increase in biomarker research and molecular profiling efforts implies that the processes based on such technologies will be widely adopted by pharmaceutical R&D labs, biotech firms, and diagnostic research labs.  

India Biochip Market Restraint

High Manufacturing Costs and Limited Domestic Fabrication Capabilities

To create and manufacture biochips, several technical materials and specialized precision micro-manufacturing technologies and surfaces must be utilized, in addition to biocompatible coatings and sophisticated quality-control measures. These features mean that biochip manufacturing requires a very high initial investment, as the technologies being developed are used for such products as DNA biochips, protein chips, and the so-called integrated microfluidic platforms. Limited access to specialized fabrication capability and dependence on imported substrates and raw materials, as well as precision parts, add to the manufacturing costs, lengthen timeframes for commercialization of the developed products, and limit the capabilities of domestic manufacturers to compete with global players in the field of biochip manufacturing. For example, to be able to produce microfluidic and molecular diagnostic chips, several tasks must first be completed, namely defining the accurate geometry of the channels, achieving proper surface properties, and ensuring high reproducibility of the measurements. All this means that Indian companies dealing with biochip manufacturing, especially with biochip scale-up from pilot to large-scale production, will have to face numerous expenses for validation of their technologies.

India Biochip Market Opportunities

Growing Opportunity for Indigenous Biochip Development and Healthcare Technology Localization

India aims to boost homegrown medical device manufacturing and biotechnology capabilities, and this is enabling stakeholders to create, develop, and market biochip technologies meant for the country's healthcare needs. The growing demand for low-cost molecular diagnostic solutions, disease detection, tumor identification, and non-centralized laboratory testing is aiding manufacturers to allocate resources for microfluidic chip manufacturing, biosensor incorporation, disposable diagnostic cartridges, and all-in-one lab-on-a-chip models. As an example, Molbio Diagnostics' Truenat system shows the commercial viability of local technology in this area due to its products and disposable micro-PCR chips used in medicine for TB and other diseases. Achira Labs' Fabchip technology also opens possibilities for local technologies in microfluidics. In terms of policies, India's BioE3 Policy, approved in August 2024, is promising a facilitating environment via establishing biofoundries, biomanufacturing facilities, and infrastructure to implement related technology solutions. As per the Department of Science and Technology data published in July 2026, more than 270 projects were successful in applying for funding through the policy's discovery, technology application, and technology scaling stages. Nonetheless, the aforementioned projects do not target biochips directly; however, the overall support provided can help domestic biochip practitioners. This creates opportunities for Indian manufacturers to strengthen in-house fabrication capabilities, reduce reliance on imported components, improve production economics and develop application-specific biochip products for domestic healthcare providers and international markets.

India Biochip Market Scope

Report Attributes

Description

Market Size in 2026

USD 0.25 Billion

Market Forecast in 2034

USD 0.72 Billion

CAGR % 2026-2034

14.7%

Market Concentration

Highly Fragmented

Base Year

2025

Historic Data

2021-2025

Forecast Period

2026-2034

Report USP


Production, company share, company heatmap, company production capacity, growth factors, and more

Geography

India

Segments Covered

  • By Type

  • By Product

  • By Application

  • By End User

Key Demand Side Trends

  • Growing Adoption of Point-of-Care Biochip Testing

  • Increasing Preference for Multiplexed Diagnostic Testing

  • Rising Demand for Precision Medicine and Genomic Analysis

Key Supply Side Trends 

  • Integration of Microfluidics with Biosensor and Molecular Detection Technologies

  • Increasing Focus on Indigenous Biochip Design and Manufacturing

  • Development of Application-Specific and Scalable Biochip Platforms

Major Players 

  • Molbio Diagnostics Private Limited

  • Huwel Lifesciences Private Limited

  • Achira Labs Private Limited

  • Point-of-Care Microfluidics Private Limited

  • PathShodh Healthcare Private Limited

  • Biosense Technologies Private Limited

India Biochip Market Report Segmentation Analysis

DNA Chips Segment Is Expected to Dominate the India Biochip Market During the Forecast Period

The DNA chips segment is anticipated to occupy a significant position in the India Biochip Market, driven by the rising usage of genomic examination, profiling of gene expression, testing of genes, and molecular diagnostics. The growing preference for early detection and understanding of diseases drives the popularity of DNA microarrays in diagnostic laboratories, the biotechnology industry, and pharmaceutical research facilities. Rapid progress in genome processing, personalized therapy and oncology techniques, and also increased industry demand for R&D activities are supporting the increased usage of DNA chip technology.


India Biochip Market Size By Segments

Consumables Segment Is Expected to Dominate the India Biochip Market During the Forecast Period

The consumables segment is expected to dominate the India Biochip Market during the forecast period due to the recurring need for disposable chips, assay reagents, cartridges, sample preparation materials, and other testing components. As opposed to instruments and integrated biochip systems, consumables are needed for individual test procedures and must be refilled regularly, generating repeat demand from diagnostic laboratories, hospitals, biotechnology companies and pharmaceutical research facilities. Rising adoption of molecular diagnostics, microfluidic platforms, and multiplexed bioassays is further driving consumption of application-specific chip cartridges and reagents. Furthermore, the recurring procurement due to the growth in decentralized diagnostic testing and routine laboratory workflows is expected to continue to make consumables a major revenue-generating segment.

Disease Diagnostics Segment Is Expected to Dominate the India Biochip Market During the Forecast Period

The Disease Diagnostics segment is anticipated to hold the largest share of the India Biochip Market during the forecast period owing to the increasing demand for quick, accurate, and economical detection of infectious diseases, cancer, and genetic conditions. The demand for diagnostic testing in India is huge, and there is growing emphasis on detecting disease early. This is leading to the use of DNA chips, biosensor chips, and microfluidic diagnostic platforms. These technologies allow for the identification of multiple biological markers, variations in genes, and disease-associated targets while reducing the need for samples and the complexity of testing. The growing demand for tuberculosis testing, infectious disease screening, oncology biomarker identification, and molecular profiling is driving opportunities for biochip-based diagnostic solutions. Moreover, the advent of portable and integrated diagnostic platforms is moving testing capabilities beyond central laboratories.

Biotechnology and Pharmaceutical Companies Segment Is Expected to Dominate the India Biochip Market During the Forecast Period 

The biotechnology and pharmaceutical companies segment is expected to account for the largest share of the India Biochip Market during the forecast period owing to rising investments in drug discovery, genomic studies, biomarker discovery and development of targeted therapies. Biotech and pharmaceutical companies make use of biochips to study gene expression, molecular profiling, toxicity, interaction studies & evaluate potential drug candidates. DNA chips, protein chips, and cell-based biochips are used by pharmaceutical and biotechnology companies to understand various biological parameters at the same time, leading to increased efficiency in their research. The increasing pharmaceutical manufacturing industry in India, along with an increasing biotechnology industry is also boosting demand from this segment. The requirement to speed up R&D and improve pre-clinical research efficiency is also expected to boost adoption of high-end biochip products among biotech and pharma companies.

The following segments are part of an in-depth analysis of the India Biochip Market:

Market Segments

By Type

  • DNA Chips

  • Protein Chips

  • Lab-on-a-Chip (LOC)

  • Cell Arrays

  • Others

By Product

  • Consumables

  • Instruments

  • Software and Services

By Application

  • Disease Diagnostics

  • Drug Discovery and Development

  • Genomics

  • Agricultural Biotechnology

  • Others

By End User

  • Biotechnology and Pharmaceutical Companies

  • Hospitals and Diagnostic Centers

  • Academic and Research Institutes

  • Others

India Biochip Market Competition Landscape Analysis

India biochip market is moderately fragmented and growing, with many indigenous players offering different kinds of biochips such as molecular diagnostic chips, microfluidic chips, biosensors, and lab-on-chip systems. Molbio Diagnostics is fairly well positioned in the market with its successful Truenat molecular diagnostic chip-based system. Others such as Achira Labs and Huwel Lifesciences offer microfluidic and nucleic acid-based diagnostics. MyLab Discovery Solutions, Point-of-Care Microfluidics and PathShodh Healthcare offer molecular diagnostic systems, bespoke lab-on-chip devices and biosensor systems, respectively. Further players such as Amar Biosystems, Adiuvo Diagnostics, Technoculture Research and Biosense Technologies are working on niche areas of microfluidics, diagnostic cartridge systems and point-of-care devices. The market is competitive, with players looking to provide differentiated products, fabrication capabilities, high accuracy, compatibility, regulatory compliance, scalable production, and cost-effective devices. While Molbio is fairly well positioned compared to most indigenous specialists, the overall market is fragmented, and there is no accurate public data to show what percentage of the market the top 6 manufacturers hold.

India Biochip Market Recent Developments News:

  • In July 2026, Achira Labs Private Limited was selected under the Government of India's Promotion of Research and Innovation in Pharma-MedTech (PRIP) Scheme, in the novel medical devices category. In collaboration with the Tata Institute for Genetics and Society, the company will develop a multiplexed microfluidic diagnostic platform capable of detecting dengue, malaria, chikungunya, and typhoid using a single finger-prick blood sample. This development strengthens its position in indigenous lab-on-chip technologies and multiplexed point-of-care diagnostics.  

  • In March 2026, Huwel Lifesciences Private Limited entered into an expanded business collaboration with Avio Smart Market Stack (formerly Bartronics India Limited) following an MoU signed in September 2025. The partnership focuses on business development and project execution for Huwel's molecular diagnostic products, including its tuberculosis testing platform. Its Quantiplus MTB FAST platform was reported to have undergone a Health Technology Assessment by the Department of Health Research, with an estimated testing cost of approximately INR 340 per sample, compared with INR 700–1,000 for conventional molecular testing systems cited in the assessment.

The India Biochip Market is dominated by a few large companies, such as

  • Molbio Diagnostics Private Limited

  • Huwel Lifesciences Private Limited

  • Achira Labs Private Limited

  • MyLab Discovery Solutions Private Limited

  • Point-of-Care Microfluidics Private Limited

  • PathShodh Healthcare Private Limited

  • Amar Biosystems Private Limited

  • Adiuvo Diagnostics Private Limited

  • Technoculture Research Private Limited

  • Cleome Innovations Private Limited

  • Biosense Technologies Private Limited

  • ISMO Bio-Photonics Private Limited

  • NeoDx Biotech Labs Private Limited

  • J. Mitra & Co. Private Limited

  • 3B BlackBio Dx Limited

  • Other Prominent Players 

Frequently Asked Questions

The market is valued at USD 0.25 billion in 2026.
The market is projected to reach USD 0.72 billion by 2034.
The market is expected to register a 14.7% CAGR.
DNA Chips are expected to dominate.
Author Biography
Swetal (Research Analyst)

Swetal is a Research Analyst with 4+ years of experience specializing in healthcare market research, medical devices, healthcare IT, and medical technology industry analysis. Her expertise includes competitive intelligence, secondary research, market trend forecasting, and healthcare business insights across global healthcare ecosystems.

She contributes to advanced market research reports by analyzing regulatory frameworks, emerging healthcare technologies, competitive landscapes, and innovation trends shaping the medical industry. With a strong focus on accurate market intelligence, strategic insights, and healthcare industry trends, Swetal supports businesses in making informed, data-backed decisions in a rapidly transforming healthcare environment.

  1. India Biochip Market Introduction and Market Overview

  1. Objectives of the Study

  2. Market Segmentation

    1. Type of the India Biochip Market

    2. Products of the India Biochip Market

    3. Application of the India Biochip Market

    4. End User of the India Biochip Market

  3. Competition Coverage List of Market Participants

  4. Market Definition: Biochip Market 

  1. Executive Summary

    1. India Biochip Market Estimation & Forecast

      1. India Biochip Market Size (US$ Million) Estimates & Historical Trend Analysis (2021 - 2025)

      2. India Peptide Cancer Vaccine Overall Market Size (US$ Million), Growth Rate (Y-o-Y), Market CAGR (%), Market Forecast (2026 - 2034)

    2. Snapshot of India Biochip Market

    3. India Biochip Market Revenue Share (%) 2025

    4. Key Competitors & Key Insights

  2. Market Overview (Qualitative Analysis)

    1. Demand Side Trends

    2. Supply Side Trends / Manufacturing Trends

    3. Demand and Opportunity Assessment, 2026 - 2034

    4. Market Dynamics

      1. Drivers

      2. Limitations 

      3. Opportunities

      4. Impact Analysis of Drivers and Restraints

    5. Key Developments 

    6. Regulatory Landscape

    7. Pricing Analysis

    8. Supply Chain Analysis

    9. Porter’s Five Forces Analysis

      1. Bargaining Power of Suppliers

      2. Bargaining Power of Buyers

      3. Threat of Substitutes

      4. Threat of New Entrants

      5. Competitive Rivalry

    10. PEST Analysis

      1. Political Factors

      2. Economic Factors

      3. Social Factors

      4. Technology Factors

  3. India Biochip Market Estimates & Forecast Trend Analysis, by Type

    1. India Biochip Market Assessments & Key Findings, by Type

    2. India Biochip Market Revenue (US$ Million) Estimates and Forecasts, by Type, 2021 - 2034

      1.  Protein Chips

      2. Lab-on-a-Chip (LOC)

      3. Cell Arrays

      4. Others

  4. India Biochip Market Estimates & Forecast Trend Analysis, by Product

    1. India Biochip Market Assessments & Key Findings, by Product

    2. India Biochip Market Revenue (US$ Million) Estimates and Forecasts, by Product, 2021 - 2034

      1. Consumables

      2. Instruments

      3. Software and Services

  5. India Biochip Market Estimates & Forecast Trend Analysis, by Application

    1. India Biochip Market Assessments & Key Findings, by Application

    2. India Biochip Market Revenue (US$ Million) Estimates and Forecasts, by Application, 2021 - 2034

      1. Disease Diagnostics

      2. Drug Discovery and Development

      3. Genomics

      4. Agricultural Biotechnology

      5. Others

  6. India Biochip Market Estimates & Forecast Trend Analysis, by End User

    1. India Biochip Market Assessments & Key Findings, by End User

    2. India Biochip Market Revenue (US$ Million) Estimates and Forecasts, by End User, 2021 - 2034

      1. Biotechnology and Pharmaceutical Companies

      2. Hospitals and Diagnostic Center

      3. Academic and Research Institutes

      4. Others

  7. Competition Landscape

    1. India Biochip Market Product Mapping

    2. India Biochip Market Concentration Analysis, by Leading Players / Innovators / Emerging Players / New Entrants

    3. India Biochip Market Tier Structure Analysis

    4. India Biochip Market Concentration & Company Market Shares (%) Analysis, 2025

  8. Company Profiles

    1. Molbio Diagnostics Private Limited

      1. Company Overview & Key Stats

      2. Financial Performance & KPIs

      3. Product Portfolio

      4. SWOT Analysis

      5. Business Strategy & Recent Developments

* Similar details would be provided for all the players mentioned below 

  1. Huwel Lifesciences Private Limited

  2. Achira Labs Private Limited

  3. MyLab Discovery Solutions Private Limited

  4. Point-of-Care Microfluidics Private Limited

  5. PathShodh Healthcare Private Limited

  6. Amar Biosystems Private Limited

  7. Adiuvo Diagnostics Private Limited

  8. Technoculture Research Private Limited

  9. Cleome Innovations Private Limited

  10. Biosense Technologies Private Limited

  11. ISMO Bio-Photonics Private Limited

  12. NeoDx Biotech Labs Private Limited 

  13. J. Mitra & Co. Private Limited

  14. 3B BlackBio Dx Limited

  15. Other Prominent Players 

  1. Research Findings & Conclusion

  2. Assumptions & Acronyms Used

  3. Research Methodology

    1. External Transportation / Databases

    2. Internal Proprietary Database

    3. Primary Research

    4. Secondary Research

    5. Assumptions

    6. Limitations

    7. Report FAQs

Our Research Methodology

"Insight without rigor is just noise."

We follow a comprehensive, multi-phase research framework designed to deliver accurate, strategic, and decision-ready intelligence. Our process integrates primary and secondary research , both quantitative and qualitative , along with dual modeling techniques ( top-down and bottom-up) and a final layer of validation through our proprietary in-house repository.

PRIMARY RESEARCH

Primary research captures real-time, firsthand insights from the market to understand behaviors, motivations, and emerging trends.

1. Quantitative Primary Research

Objective: Generate statistically significant data directly from market participants.

Approaches:
  • Structured surveys with customers, distributors, and field agents
  • Mobile-based data collection for point-of-sale audits and usage behavior
  • Phone-based interviews (CATI) for market sizing and product feedback
  • Online polling around industry events and digital campaigns
Insights generated:
  • Purchase frequency by customer type
  • Channel performance across geographies
  • Feature demand by application or demographic

2. Qualitative Primary Research

Objective: Explore decision-making drivers, pain points, and market readiness.

Approaches:
  • In-depth interviews (IDIs) with executives, product managers, and key decision-makers
  • Focus groups among end users and early adopters
  • Site visits and observational research for consumer products
  • Informal field-level discussions for regional and cultural nuances

SECONDARY RESEARCH

This phase helps establish a macro-to-micro understanding of market trends, size, regulation, and competitive dynamics, sourced from credible and public domain information.

1. Quantitative Secondary Research

Objective: Model market value and segment-level forecasts based on published data.

Sources include:
  • Financial reports and investor summaries
  • Government trade data, customs records, and regulatory statistics
  • Industry association publications and economic databases
  • Channel performance and pricing data from marketplace listings
Key outputs:
  • Revenue splits, pricing trends, and CAGR estimates
  • Supply-side capacity and volume tracking
  • Investment analysis and funding benchmarks

2. Qualitative Secondary Research

Objective: Capture strategic direction, innovation signals, and behavioral trends.

Sources include:
  • Company announcements, roadmaps, and product pipelines
  • Publicly available whitepapers, conference abstracts, and academic research
  • Regulatory body publications and policy briefs
  • Social and media sentiment scanning for early-stage shifts
Insights extracted:
  • Strategic shifts in market positioning
  • Unmet needs and white spaces
  • Regulatory triggers and compliance impact
Market Research Process

DUAL MODELING: TOP-DOWN + BOTTOM-UP

To ensure robust market estimation, we apply two complementary sizing approaches:

Top-Down Modeling:
  • Start with broader industry value (e.g., global or regional TAM)
  • Apply filters by segment, geography, end-user, or use case
  • Adjust with primary insights and validation benchmarks
  • Ideal for investor-grade market scans and opportunity mapping
Bottom-Up Modeling
  • Aggregate from the ground up using sales volumes, pricing, and unit economics
  • Use internal modeling templates aligned with stakeholder data
  • Incorporate distributor-level or region-specific inputs
  • Most accurate for emerging segments and granular sub-markets

DATA VALIDATION: IN-HOUSE REPOSITORY

We close the loop with proprietary data intelligence built from ongoing projects, industry monitoring, and historical benchmarking. This repository includes:

  • Multi-sector market and pricing models
  • Key trendlines from past interviews and forecasts
  • Benchmarked adoption rates, churn patterns, and ROI indicators
  • Industry-specific deviation flags and cross-check logic
Benefits:
  • Catches inconsistencies early
  • Aligns projections across studies
  • Enables consistent, high-trust deliverables